Livedo reticularis heralding hypercalcaemia of malignancy.
The term livedo reticularis is used to describe net-like purple rash usually on the lower limbs. It is an important clinical sign with diverse aetiologies. Hypercalcaemia is an uncommon but important clinical entity, sometimes associated with livedo reticularis. Generally, hypercalcaemia of renal failure and secondary hyperparathyroidism has been reported with this condition. We report a case of livedo reticularis heralding onset of hypercalcaemia of malignancy.
Department of Medical Oncology, Dharamshila Hospital, New Delhi, India.
Deepak
D
Sundriyal
Department of Internal Medicine, PGIMER & Dr Ram Manohar Lohia Hospital, New Delhi, India.
Naveen
N
Kumar
Department of Medicine, V.M.M.C. and Safdarjung Hospital, New Delhi, India.
Gaurav
G
Kumar
Department of Medical Oncology, Dharamshila Hospital, New Delhi, India.
Meenu
M
Walia
D002116:Calcitonin / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000175:diagnosis* / Q000601:surgery; D004164:Diphosphonates / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005440:Fluid Therapy / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D006934:Hypercalcemia / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D007093:Imidazoles / Q000627:therapeutic use; D054068:Livedo Reticularis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D009062:Mouth Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000601:surgery; D018570:Risk Assessment; D016896:Treatment Outcome; D000077211:Zoledronic Acid
D004164:Diphosphonates; D004232:Diuretics; D007093:Imidazoles; D000077211:Zoledronic Acid; D002116:Calcitonin